Cyclo Therapeutics Presents Preliminary Data From Phase 3 TransportNPC Study Of Trappsol With 6 Of 7 Patients Showing Stabilization Or Improvement In Clinical Global Impression Over 48 Weeks; Topline 48-Week Interim Data Expected in H1 2025
Author: Benzinga Newsdesk | February 07, 2025 09:09am